Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04531241 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing Technology
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
NCT04531241 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 136 participants.
The verdict
NCT04531241, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
Study Summary
This study is a multi-site, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear bilaterally both Test and Control lenses in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the wearing periods.
Interventions
- DEVICE ACUVUE® OASYS 1-DAY
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2020-08-05 |
| Est. Completion | 2020-09-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04531241
The ClinicalTrials.gov registry entry for NCT04531241 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ACUVUE® OASYS 1-DAY is the first listed.
NCT04531241 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04531241 about?
NCT04531241 is a clinical study titled "Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing Technology". This study is a multi-site, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear bilaterally both Test and Control lenses in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the wearing periods.
What is the current status of trial NCT04531241?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2020-08-05. Estimated completion is 2020-09-25.
What interventions are being tested in trial NCT04531241?
The interventions under investigation include: ACUVUE® OASYS 1-DAY (DEVICE).
Who is sponsoring clinical trial NCT04531241?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.